SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001222128-04-000001
Filing Date
2004-02-20
Accepted
2004-02-20 11:15:45
Documents
1
Period of Report
2004-02-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3830
  Complete submission text file 0001222128-04-000001.txt   5544
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 30 W 88TH ST APT 4 NEW YORK NY 10024
Business Address
CLARK JEFF D (Reporting) CIK: 0001222128 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 04618152